Quality Control in Clinical Biochemistry — MCQs
What is the range of values for the Physical Quality of Life Index (PQLI)?
If a biochemical test gives the same reading for a sample on repeated testing, it is inferred that the measurement is -
Which of the following is not a part of case-control studies?
Most appropriate measure for central tendency when data includes extreme values?
First-line acute management of febrile convulsion in hospital setting includes
Which of the following is an example of placebo?
What is a key benefit of Randomized Controlled Trials (RCTs) in clinical research?
Which of the following conditions masks low serum haptoglobin in hemolysis?
Which of the following vitamin deficiencies is found in patients with gastric cancer?
In carcinoma prostate with metastasis, which of the following biochemical markers is typically elevated?
Quality Control in Clinical Biochemistry Indian Medical PG Practice Questions and MCQs
Question 1: What is the range of values for the Physical Quality of Life Index (PQLI)?
- A. 0 to 10
- B. 0 to 50
- C. 0 to 100 (Correct Answer)
- D. 100 to 200
Explanation: ***0 to 100*** - The **Physical Quality of Life Index (PQLI)** is an index that measures the quality of life or well-being of a country, with values ranging from **0 (worst)** to **100 (best)**. - This standardized range allows for easy comparison of living standards and societal progress across different nations. *0 to 10* - This range is too small and does not accurately represent the comprehensive scoring system used for the **PQLI**, which aggregates multiple indicators. - While some individual metrics might use a 0-10 scale, the composite PQLI itself uses a broader range. *0 to 50* - This range is insufficient to capture the full spectrum of development indicators factored into the **PQLI**. - A maximum value of 50 would compress the data too much, making fine distinctions between countries less apparent. *100 to 200* - The **PQLI** is capped at 100, which signifies the highest possible quality of life; therefore, values above 100 are not possible. - This range suggests an overly optimistic or unstandardized index, which is not the case for PQLI.
Question 2: If a biochemical test gives the same reading for a sample on repeated testing, it is inferred that the measurement is -
- A. Specific
- B. Accurate
- C. Sensitive
- D. Precise (Correct Answer)
Explanation: ***Precise*** - **Precision** refers to the consistency or **reproducibility** of measurements. If repeated tests yield similar results, the measurement is considered precise. - A precise test may not necessarily be accurate, but it consistently gives the same value, highlighting its **reliability** in producing repeatable results. *Specific* - **Specificity** refers to a test's ability to correctly identify individuals who do **not** have a particular condition (i.e., true negatives). - It measures how well a test avoids **false positives**, indicating that a positive result is truly associated with the target analyte. *Accurate* - **Accuracy** refers to how close a measured value is to the true or **actual value**. - A test is accurate if it provides results that are close to the correct value, not simply if they are consistently the same. *Sensitive* - **Sensitivity** refers to a test's ability to correctly identify individuals who **do** have a particular condition (i.e., true positives). - It measures how well a test avoids **false negatives**, indicating that a negative result truly means the condition is absent.
Question 3: Which of the following is not a part of case-control studies?
- A. Strength of association
- B. Follow up (Correct Answer)
- C. Matching
- D. Selection of study subjects
Explanation: ***Follow up*** - **Follow-up** of participants over time to observe disease incidence or outcomes is a characteristic of **cohort studies**, not case-control studies. - Case-control studies are typically **retrospective**, looking back in time after disease occurrence. *Strength of association* - Measuring the **strength of association** between an exposure and an outcome using metrics like the **odds ratio** is a primary objective of case-control studies. - This helps quantify the increased risk of disease attributable to a particular exposure. *Matching* - **Matching** is a technique frequently used in case-control studies to control for **confounding variables** by selecting controls who are similar to cases in terms of age, gender, or other relevant factors. - This helps ensure that any observed association is truly due to the exposure and not other differences between the groups. *Selection of study subjects* - The **selection of study subjects** is fundamental in case-control studies, involving the identification of individuals with the disease (**cases**) and a comparable group without the disease (**controls**). - Careful selection is crucial to minimize bias and ensure the validity of the study findings.
Question 4: Most appropriate measure for central tendency when data includes extreme values?
- A. Mode
- B. Mean
- C. Median (Correct Answer)
- D. Geometric mean
Explanation: ***Median*** - The **median** is less affected by **extreme values** or **outliers** because it represents the middle value in an ordered dataset. - It provides a more robust measure of central tendency when the data distribution is **skewed**. *Mode* - The **mode** represents the most frequently occurring value in a dataset; it does not account for the magnitude of other values. - While it is not influenced by extreme values, it may not accurately represent the central tendency of a continuous dataset, especially if there are **multiple modes** or if the most frequent value is not central. *Mean* - The **mean** is calculated by summing all values and dividing by the number of values, making it highly susceptible to **extreme values** or **outliers**. - A single very large or very small value can significantly distort the mean, pulling it away from the true center of most data points. *Geometric mean* - The **geometric mean** is primarily used for data that is **multiplicative** in nature or when dealing with rates of change, or positively skewed distributions. - While it can be less sensitive to extreme values than the arithmetic mean for certain types of data, it is not the most appropriate general measure for central tendency when outliers are present without specific multiplicative contexts.
Question 5: First-line acute management of febrile convulsion in hospital setting includes
- A. Immediate IV phenytoin loading
- B. IV lorazepam administration (Correct Answer)
- C. Rectal diazepam
- D. Oral carbamazepine prophylaxis
Explanation: ***IV lorazepam administration*** - **Intravenous lorazepam** is a first-line treatment for acute febrile convulsions, especially in a hospital setting, due to its rapid onset and effectiveness in terminating seizures. - As a **benzodiazepine**, it enhances the effect of GABA, leading to CNS depression and seizure cessation. *Immediate IV phenytoin loading* - **Phenytoin** is typically used for long-term seizure control or in refractory status epilepticus, not as a first-line acute agent for febrile convulsions. - Its slower onset of action makes it less suitable for immediate seizure termination compared to benzodiazepines. *Rectal diazepam* - **Rectal diazepam** is often used for acute seizure management in the **pre-hospital setting** or at home when IV access is not readily available. - In a hospital setting, IV administration of benzodiazepines is preferred due to more precise dosing and faster action. *Oral carbamazepine prophylaxis* - **Carbamazepine** is an anti-epileptic drug used for **long-term prevention** of certain types of seizures, but it is not indicated for acute management of febrile convulsions. - It is not routinely recommended for prophylaxis of recurrent febrile seizures.
Question 6: Which of the following is an example of placebo?
- A. Cognitive behavioral therapy
- B. Sugar pill given as medication
- C. Physiotherapy
- D. Sham surgery (Correct Answer)
Explanation: ***Sham surgery*** - Sham surgery involves a **mock surgical procedure** performed on a patient without the actual therapeutic intervention, often used as a control in clinical trials. - Its purpose is to account for the **placebo effect** of the surgical experience itself, including anesthesia and incisions, independent of the direct physiological effects of the surgery. *Cognitive behavioral therapy* - **Cognitive behavioral therapy (CBT)** is a structured psychotherapy that helps individuals identify and change negative thought patterns and behaviors [1]. - It is a **specific, active treatment** with established mechanisms of action, not merely an inert substance or procedure [1]. *Sugar pill given as medication* - While a **sugar pill** is a classic example of a placebo, the question asks for *an* example of a placebo, and sham surgery is also a valid and often more complex form. - A sugar pill's effect primarily stems from the **expectation of relief** from a medication. *Physiotherapy* - **Physiotherapy** involves physical methods (e.g., exercise, massage, heat therapy) to treat disease, injury, or deformity. - It is an **active therapeutic intervention** with direct physiological and biomechanical effects, not an inert or non-specific treatment.
Question 7: What is a key benefit of Randomized Controlled Trials (RCTs) in clinical research?
- A. They can be conducted more quickly than other study types.
- B. They minimize selection bias. (Correct Answer)
- C. They are ideal for studying rare diseases.
- D. They are generally less expensive than other study types.
Explanation: ***They minimize selection bias.*** - **Randomization** in RCTs ensures that participants have an equal chance of being assigned to any of the treatment groups, thereby balancing potential **confounding factors** across groups. - This balance helps to ensure that any observed differences in outcomes between groups are more likely due to the intervention being studied rather than pre-existing differences among participants, thus minimizing **selection bias**. *They can be conducted more quickly than other study types.* - RCTs often require **extensive planning**, recruitment, and follow-up periods, making them one of the **most time-consuming** study designs. - The need for sufficient **power** to detect meaningful differences often translates into longer study durations. *They are ideal for studying rare diseases.* - Due to the requirement for **large sample sizes** to demonstrate statistical significance, RCTs are **not practical** for diseases with low prevalence. - Recruiting enough participants with a rare disease for an RCT can be extremely challenging and often **unfeasible**. *They are generally less expensive than other study types.* - RCTs are typically among the **most expensive** study designs because they involve extensive participant recruitment, intervention administration, data collection, and long-term follow-up. - The costs associated with staff, resources, and monitoring for ethical compliance contribute to their **high financial burden**.
Question 8: Which of the following conditions masks low serum haptoglobin in hemolysis?
- A. Bile duct obstruction (Correct Answer)
- B. Liver disease
- C. Malnutrition
- D. Pregnancy
Explanation: **Explanation:** The primary clinical utility of **Haptoglobin** is as a marker for **intravascular hemolysis**. Haptoglobin is an acute-phase reactant synthesized by the liver that binds free hemoglobin. During hemolysis, haptoglobin levels drop significantly as it is cleared by the reticuloendothelial system. **Why Bile Duct Obstruction is correct:** Haptoglobin is a **positive acute-phase reactant**. In conditions like **bile duct obstruction (obstructive jaundice)**, inflammation or biliary stasis triggers an increase in the hepatic synthesis of haptoglobin. This elevation can artificially "mask" or normalize the low levels typically seen in hemolysis, leading to a false-negative result for hemolytic anemia. **Analysis of Incorrect Options:** * **Liver Disease:** Since haptoglobin is synthesized in the liver, severe liver disease (e.g., cirrhosis) leads to **decreased** production. This would mimic or exacerbate low levels rather than masking them. * **Malnutrition:** Protein-energy malnutrition leads to a generalized decrease in plasma protein synthesis, including haptoglobin, resulting in **low** levels. * **Pregnancy:** Pregnancy is associated with a physiological decrease in haptoglobin levels (estrogen effect), which would not mask a hemolytic state. **NEET-PG High-Yield Pearls:** * **Gold Standard for Hemolysis:** A **decreased** serum haptoglobin level is one of the most sensitive markers for confirming hemolysis. * **Acute Phase Reactants:** Remember that haptoglobin levels rise in infection, trauma, and malignancy, which can confound the diagnosis of co-existing hemolysis. * **Neonate Fact:** Haptoglobin levels are naturally very low or absent in newborns (physiologic ahaptoglobinemia) and reach adult levels by 6 months of age.
Question 9: Which of the following vitamin deficiencies is found in patients with gastric cancer?
- A. Vitamin C
- B. Vitamin B12 (Correct Answer)
- C. Vitamin A
- D. Vitamin D
Explanation: **Explanation:** The correct answer is **Vitamin B12**. **Why Vitamin B12 is the correct answer:** Gastric cancer often involves the destruction or surgical resection of the gastric mucosa, specifically the **parietal cells** located in the body and fundus of the stomach. These cells are responsible for secreting **Intrinsic Factor (IF)**. Vitamin B12 (cobalamin) requires IF to form a complex that survives the acidic environment of the stomach and allows for absorption in the **terminal ileum**. In gastric cancer, the loss of parietal cells leads to IF deficiency, resulting in secondary Vitamin B12 malabsorption and potentially megaloblastic anemia (pernicious-like state). Additionally, the achlorhydria (lack of HCl) associated with gastric atrophy prevents the release of B12 from dietary proteins. **Why the other options are incorrect:** * **Vitamin C:** While low levels are associated with an increased *risk* of developing gastric cancer due to reduced antioxidant protection, the cancer itself does not characteristically cause a deficiency through a specific physiological mechanism like B12. * **Vitamin A & D:** These are fat-soluble vitamins. Their deficiency is typically associated with fat malabsorption syndromes (e.g., pancreatic insufficiency, biliary obstruction, or celiac disease) rather than the specific loss of gastric intrinsic factor. **High-Yield Clinical Pearls for NEET-PG:** * **Site of Absorption:** Vitamin B12 is absorbed in the **terminal ileum**, while Iron is absorbed in the **duodenum**. * **Post-Gastrectomy:** Patients undergoing total gastrectomy for gastric cancer *must* receive lifelong parenteral Vitamin B12 supplementation. * **Schilling Test:** Historically used to differentiate between causes of B12 deficiency (though largely replaced by antibody testing and metabolite levels). * **Associated Finding:** Look for **hypersegmented neutrophils** on a peripheral smear in patients with B12 deficiency.
Question 10: In carcinoma prostate with metastasis, which of the following biochemical markers is typically elevated?
- A. Erythrocyte Sedimentation Rate (ESR)
- B. Alkaline Phosphatase (Correct Answer)
- C. Acid Phosphatase
- D. Bilirubin
Explanation: **Explanation:** The correct answer is **Alkaline Phosphatase (ALP)**. In the context of prostate carcinoma, elevation of ALP is a hallmark of **osteoblastic (bone-forming) metastasis**. When prostate cancer cells spread to the bone, they stimulate osteoblasts to lay down new mineralized bone. ALP is a byproduct of osteoblastic activity; hence, its serum levels rise significantly as a marker of bone remodeling and turnover. **Analysis of Options:** * **Alkaline Phosphatase (Correct):** It is the most sensitive marker for detecting osteoblastic skeletal metastases in prostate cancer patients. * **Acid Phosphatase (Incorrect):** Specifically, Prostatic Acid Phosphatase (PAP) was historically used to diagnose prostate cancer. However, it is a marker of the **primary tumor burden** and soft tissue extension rather than bone metastasis specifically. It has largely been replaced by PSA (Prostate-Specific Antigen) in modern practice. * **ESR (Incorrect):** While ESR may be elevated in chronic malignancies or inflammation, it is a non-specific marker and not a diagnostic biochemical indicator for metastatic prostate cancer. * **Bilirubin (Incorrect):** Bilirubin is a marker of hepatobiliary disease or hemolysis and is not typically elevated in prostate cancer unless there is extensive, rare liver metastasis. **High-Yield Clinical Pearls for NEET-PG:** 1. **PSA (Prostate-Specific Antigen):** The most sensitive and specific marker for screening, monitoring, and detecting recurrence of prostate cancer. 2. **Osteoblastic vs. Osteolytic:** Prostate cancer typically causes **osteoblastic** lesions (High ALP), whereas Multiple Myeloma causes **osteolytic** lesions (Normal ALP). 3. **Acid Phosphatase:** If the question asks for a marker that correlates with the *volume* of the primary tumor or extra-capsular spread, PAP is the traditional answer.
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
Start For Free